Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients
Background: The systemic inflammatory response following severe COVID-19 is associated with poor outcomes. Several anti-inflammatory medications have been studied in COVID-19 patients. Xanthohumol (Xn), a natural extract from hop cones, possesses strong anti-inflammatory and antioxidative properties...
Main Authors: | Wojciech Dabrowski, Mariusz Gagos, Dorota Siwicka-Gieroba, Mariusz Piechota, Jan Siwiec, Magdalena Bielacz, Katarzyna Kotfis, Andrzej Stepulak, Luiza Grzycka-Kowalczyk, Andrzej Jaroszynski, Manu LNG Malbrain |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222014718 |
Similar Items
-
Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)
by: Chuan-Hao Jiang, et al.
Published: (2018-05-01) -
Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action
by: Adrianna Sławińska-Brych, et al.
Published: (2021-06-01) -
Microbial Conjugation Studies of Licochalcones and Xanthohumol
by: Fubo Han, et al.
Published: (2021-06-01) -
Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells
by: Tatjana Seitz, et al.
Published: (2021-01-01) -
Xanthohumol-Induced Rat Glioma C6 Cells Death by Triggering Mitochondrial Stress
by: Shaozhi Hou, et al.
Published: (2021-04-01)